| 000 | 01879 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515053938.0 | ||
| 264 | 0 | _c20070321 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6603493 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBajetta, E | |
| 245 | 0 | 0 |
_aUracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cFeb 2007 |
||
| 300 |
_a439-44 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCamptothecin _xadministration & dosage |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIrinotecan |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 |
_aTegafur _xadministration & dosage |
| 650 | 0 | 4 |
_aUracil _xadministration & dosage |
| 700 | 1 | _aDi Bartolomeo, M | |
| 700 | 1 | _aBuzzoni, R | |
| 700 | 1 | _aMariani, L | |
| 700 | 1 | _aZilembo, N | |
| 700 | 1 | _aFerrario, E | |
| 700 | 1 | _aLo Vullo, S | |
| 700 | 1 | _aAitini, E | |
| 700 | 1 | _aIsa, L | |
| 700 | 1 | _aBarone, C | |
| 700 | 1 | _aJacobelli, S | |
| 700 | 1 | _aRecaldin, E | |
| 700 | 1 | _aPinotti, G | |
| 700 | 1 | _aIop, A | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 96 _gno. 3 _gp. 439-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6603493 _zAvailable from publisher's website |
| 999 |
_c16808502 _d16808502 |
||